JUBILANT PHARMOVA LTD.

NSE : JUBLPHARMABSE : 530019ISIN CODE : INE700A01033Industry : Pharmaceuticals & DrugsHouse : Jubilant Bhartia
BSE684.703.5 (+0.51 %)
PREV CLOSE ( ) 681.20
OPEN PRICE ( ) 685.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 684.70 (100)
VOLUME 30129
TODAY'S LOW / HIGH ( )674.50 691.15
52 WK LOW / HIGH ( )299.3 724
NSE685.304.2 (+0.62 %)
PREV CLOSE( ) 681.10
OPEN PRICE ( ) 685.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 685.30 (1172)
VOLUME 233991
TODAY'S LOW / HIGH( ) 674.90 691.35
52 WK LOW / HIGH ( )299.05 724.4
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax277.816304.4712120.1012105.319038.11
Adjustment7828.765794.747164.757607.388615.33
Changes In working Capital543.13-1782.872499.00-1796.72-3005.27
Cash Flow after changes in Working Capital8649.7010316.3421783.8517915.9714648.17
Cash Flow from Operating Activities6606.668375.4317842.6515429.3811215.11
Cash Flow from Investing Activities-5444.12-3803.70-7390.14-3270.03-10118.35
Cash Flow from Financing Activities-1566.83-325.99-17093.86-10503.706574.28
Net Cash Inflow / Outflow-404.294245.74-6641.351655.657671.04
Opening Cash & Cash Equivalents9838.195019.5712308.1410053.972441.76
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANA-769.81NANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange Fluctuations705.29572.88122.59598.52-58.83
Closing Cash & Cash Equivalent10139.199838.195019.5712308.1410053.97

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.